Literature DB >> 17423454

Prevention of foal mortality due to Rhodococcus equi pneumonia on an endemically affected farm.

J F Prescott, R Machang'u, J Kwiecien, K Delaney.   

Abstract

Over the course of one summer, foals on a horse breeding farm where Rhodococcus equi infection was endemic were examined clinically twice weekly for evidence of R. equi pneumonia. Examination usually commenced from the week of birth and continued for up to 14 weeks of age. Affected animals were treated with a variety of antimicrobial drugs and such treatment was often prolonged. For descriptive purposes, we regarded a foal as developing R. equi pneumonia if the rectal temperature rose above 39 degrees C, the respiratory rate was over 40 per min, there were characteristic associated changes in respiratory sounds on auscultation, and the foal responded to antimicrobial treatment. In a group of 16 foals followed in this way, R. equi pneumonia developed in at least 14. Seven of these foals developed antibodies to equi factors as determined in a neutralizing antibody assay. Mean age of onset of these 14 foals was 3.4 weeks. Three foals developed the disease between 1.5-2.5 weeks of age, and 12 of 14 before four weeks of age. In previous years four to six foals died on the farm each summer of R. equi pneumonia; only one foal died of R. equi pneumonia on the farm during the summer of this study, and this foal did not form part of the study group. Early clinical recognition and treatment of R. equi pneumonia in foals on endemically affected farms may be an effective way to prevent deaths due to this infection.

Entities:  

Year:  1989        PMID: 17423454      PMCID: PMC1681308     

Source DB:  PubMed          Journal:  Can Vet J        ISSN: 0008-5286            Impact factor:   1.008


  15 in total

1.  Use of erythromycin-rifampin combination in treatment of Rhodococcus equi pneumonia.

Authors:  C J Hillidge
Journal:  Vet Microbiol       Date:  1987-08       Impact factor: 3.293

Review 2.  The immunological response of foals to Rhodococcus equi: a review.

Authors:  J B Woolcock; M D Mutimer; P M Bowles
Journal:  Vet Microbiol       Date:  1987-08       Impact factor: 3.293

Review 3.  Epidemiology of Rhodococcus equi infection in horses.

Authors:  J F Prescott
Journal:  Vet Microbiol       Date:  1987-08       Impact factor: 3.293

4.  Ecology of Rhodococcus equi in horses and their environment on horse-breeding farms.

Authors:  S Takai; T Fujimori; K Katsuzaki; S Tsubaki
Journal:  Vet Microbiol       Date:  1987-08       Impact factor: 3.293

5.  Dynamics of equi-factor antibodies in sera of foals kept on farms with differing histories of Rhodococcus equi pneumonia.

Authors:  B Skalka
Journal:  Vet Microbiol       Date:  1987-08       Impact factor: 3.293

6.  Rhodococcus equi pneumonia in 48 foals: response to antimicrobial therapy.

Authors:  C R Sweeney; R W Sweeney; T J Divers
Journal:  Vet Microbiol       Date:  1987-08       Impact factor: 3.293

7.  Two techniques for detection of antibodies against Corynebacterium (Rhodococcus) equi in horse sera.

Authors:  B Skalka; A Svastová
Journal:  Vet Microbiol       Date:  1985-04       Impact factor: 3.293

8.  Quantitative aspects of fecal Rhodococcus (Corynebacterium) equi in foals.

Authors:  S Takai; H Ohkura; Y Watanabe; S Tsubaki
Journal:  J Clin Microbiol       Date:  1986-04       Impact factor: 5.948

9.  Protection of foals against experimental Rhodococcus equi pneumonia by oral immunization.

Authors:  J M Chirino-Trejo; J F Prescott; J A Yager
Journal:  Can J Vet Res       Date:  1987-10       Impact factor: 1.310

10.  Detection of Corynebacterium equi-specific antibody in horses by enzyme-linked immunosorbent assay.

Authors:  S K Hietala; A A Ardans; A Sansome
Journal:  Am J Vet Res       Date:  1985-01       Impact factor: 1.156

View more
  1 in total

1.  Purification and properties of cholesterol oxidase and choline phosphohydrolase from Rhodococcus equi.

Authors:  R S Machang'u; J F Prescott
Journal:  Can J Vet Res       Date:  1991-10       Impact factor: 1.310

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.